Home
>
National Drug Code (NDC)
>
Ramipril
Ramipril - 0093-7436-01 - (Ramipril)
Drug Information of Ramipril
| Product NDC: | 0093-7436 |
| Proprietary Name: | Ramipril |
| Non Proprietary Name: | Ramipril |
| Active Ingredient(s): | 2.5 mg/1 & nbsp; Ramipril |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Ramipril
| Product NDC: | 0093-7436 |
| Labeler Name: | Teva Pharmaceuticals USA Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077470 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20080624 |
Package Information of Ramipril
| Package NDC: | 0093-7436-01 |
| Package Description: | 100 CAPSULE in 1 BOTTLE (0093-7436-01) |
NDC Information of Ramipril
| NDC Code | 0093-7436-01 |
| Proprietary Name | Ramipril |
| Package Description | 100 CAPSULE in 1 BOTTLE (0093-7436-01) |
| Product NDC | 0093-7436 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Ramipril |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20080624 |
| Marketing Category Name | ANDA |
| Labeler Name | Teva Pharmaceuticals USA Inc |
| Substance Name | RAMIPRIL |
| Strength Number | 2.5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |
